IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 170 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $206,907 | +5.6% | 19,668 | +29.3% | 0.07% | -62.4% |
| Q2 2021 | $196,000 | +1.0% | 15,214 | +21.0% | 0.18% | +278.7% |
| Q1 2018 | $194,000 | -50.1% | 12,569 | -44.9% | 0.05% | -70.4% |
| Q1 2017 | $389,000 | -16.0% | 22,800 | -24.8% | 0.16% | -34.6% |
| Q4 2016 | $463,000 | – | 30,300 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |